Eagle Wealth Strategies’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.34M Sell
10,404
-74
-0.7% -$8.66K 0.51% 26
2026
Q1
$1.26M Buy
10,478
+2,332
+29% +$269K 0.55% 22
2025
Q4
$857K Buy
8,146
+2,200
+37% +$207K 0.4% 27
2025
Q3
$499K Buy
5,946
+148
+3% +$12.2K 0.25% 44
2025
Q2
$459K Buy
5,798
+121
+2% +$9.62K 0.26% 47
2025
Q1
$510K Sell
5,677
-690
-11% -$64.4K 0.31% 39
2024
Q4
$633K Buy
6,367
+2,869
+82% +$296K 0.46% 30
2024
Q3
$397K Buy
3,498
+68
+2% +$8.08K 0.29% 54
2024
Q2
$425K Buy
3,430
+6
+0.2% +$773 0.34% 44
2024
Q1
$449K Buy
3,424
+8
+0.2% +$986 0.36% 43
2023
Q4
$372K Buy
+3,416
New +$355K 0.22% 54

Other funds holding MRK

Eagle Wealth Strategies's MRK Position: Q2 2026 in Review

Eagle Wealth Strategies reduced its Merck (MRK) stake by 0.71% in Q2 2026, selling an estimated $8.66K and leaving 10,404 shares worth $1.34M. The position accounts for 0.51% of the portfolio, ranked #26.

Eagle Wealth Strategies first reported a position in MRK in Q4 2023 and has held it in 11 quarters since. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Eagle Wealth Strategies held 10,404 shares of Merck worth $1.34M as of Q2 2026.
  • Eagle Wealth Strategies sold 74 Merck shares in Q2 2026, an estimated $8.66K.
  • Merck made up 0.51% of Eagle Wealth Strategies's portfolio in Q2 2026, its #26 holding.
  • Eagle Wealth Strategies first reported a position in Merck in Q4 2023 and has held it in 11 quarters since.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Eagle Wealth Strategies's 13F filing for Q2 2026, filed 9 Jul 2026.